Results 151 to 160 of about 10,843 (242)

Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for Thalassemia. [PDF]

Pharmacy (Basel)
Barzegari S, Rostamian H, Firoozi-Majd E, Arpaci I.   +3 more
europepmc   +1 more source

Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major

, 2011
Khaled M. Musallam, Alì Taher
openalex   +2 more sources

Beyond blood transfusions: exploring iron chelation therapies in transfusion-dependent beta-thalassemia. [PDF]

Ann Med Surg (Lond)
Talha M, Ali MH, Hurjkaliani S, Rahmat ZS, Sadia H, Hasibuzzaman MA, Uzair AUQ.   +6 more
europepmc   +1 more source

Protective effect of deferiprone on 7-ketocholesterol formation in hemin-induced LDL oxidation

, 2014
Usa Suwannasual, Thitima Pengsuparp, Rataya Luechapudiporn   +2 more
openalex   +2 more sources

Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassaemia major: the DEEP-3 multi-centre observational safety study [PDF]

, 2018
Bonifazi, D, Botzenhardt, S, Ceci, A, Collaborative Groups: the DEEP Consortium, ., Del Vecchio, GC, Felisi, M, Kattamis, A, Neubert, A, Putti, MC, Wong, ICK   +9 more
core  

Iron Chelation Prevents Age-Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging. [PDF]

J Cachexia Sarcopenia Muscle
Bose C, Megyesi J, Karaduta O, Singh SP, Swaminathan S, Shah SV.   +5 more
europepmc   +1 more source

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes [PDF]

, 2016
Cappellini, MD, Kattamis, A, Porter, JB, Taher, AT, Viprakasit, V   +4 more
core  

Analysis of the Risk of Infection Stratified By Absolute Neutrophil Counts during Deferiprone-Associated Severe Neutropenia or Agranulocytosis

, 2023
Sherif M. Badawy, Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Leo Lin, Anna Rozova, Sujit Sheth   +7 more
openalex   +1 more source

Green Tea Extract Containing Epigallocatechin-3-Gallate Facilitates Bone Formation and Mineralization by Alleviating Iron-Overload-Induced Oxidative Stress in Human Osteoblast-like (MG-63) Cells. [PDF]

Antioxidants (Basel)
Xu H, Khantamat O, Korsieporn W, Paradee N, Li J, Zhong Y, Srichairatanakool S, Koonyosying P.   +7 more
europepmc   +1 more source

The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group

, 2023
Drorit Merkel, Shelly Soffer, Kalman Filanovsky, Andrei Braester, Eitan Fibach, Mutaz Dana, Yishai Ofran, Uri Greenbaum, Arnon Nagler, Irina Amitai, Moshe Mittelman   +10 more
openalex   +1 more source